The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population
The uninsured population has much to gain from affordable sources of prescription medications. No prior studies have assessed the prevalence and predictors of low-cost generic drug programs (LCGP) use in the uninsured population in the United States. A cross-sectional study was conducted using data...
Main Authors: | Joshua D. Brown, Nathan J. Pauly, Jeffery C. Talbert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-03-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | http://www.mdpi.com/2226-4787/4/1/14 |
Similar Items
-
Extent of Drug Coverage across Generic Drug Discount Programs offered by Community Pharmacies: A look at five Chronic Conditions
by: Harshali K. Patel, et al.
Published: (2012-01-01) -
Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
by: F. Cankat Tulunay, et al.
Published: (2010-08-01) -
Empirical Assessment of the Impact of Low-Cost Generic Programs on Adherence-Based Quality Measures
by: Nathan J. Pauly, et al.
Published: (2017-03-01) -
Factors influencing the use of the “not for generic substitution” mention for prescriptions in primary care: a survey with general practitioners
by: Virgil Beauvais, et al.
Published: (2018-11-01) -
The Potential to Reduce Patient Co-Payment and the Public Payer Spending in Poland through an Optimised Implementation of the Generic Substitution: The Win-Win Scenario Suggested by the Real-World Big Data Analysis
by: Przemysław Kardas, et al.
Published: (2021-07-01)